ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

NTX Introduces Groundbreaking Ketamine Treatment for Depression, Anxiety, PTSD, and OCD

Eugene, OR (Newsworthy.ai) Thursday Dec 21, 2023 @ 7:00 AM Eastern —

Ketamine, traditionally used as an anesthetic in emergency departments and operating rooms, has demonstrated remarkable effectiveness in addressing mental health conditions. Administered in a controlled clinical setting, ketamine injections have proven to be highly beneficial for patients seeking relief from depression, anxiety, PTSD, and OCD.

Unlike traditional antidepressants, ketamine works by regenerating synaptic connections in brain areas damaged by stress and depression. This unique mechanism enables a faster restoration of mood in individuals suffering from depression. For anxiety, ketamine reduces overactivity in the fear center of the brain, leading to a decrease in anxiety levels and an overall improvement in well-being. In PTSD cases, ketamine diminishes the impact of traumatic memories by blocking the receptor responsible for keeping these memories dominant. Furthermore, for individuals with OCD, ketamine effectively reduces the hyperconnectivity between different regions of the brain associated with obsessive and compulsive behaviors.

"Ketamine treatment presents a breakthrough opportunity for our patients, offering them a unique solution and swift relief from debilitating mental health conditions," said a Chief Medical Officer at NTX. "We are thrilled to incorporate this cutting-edge therapy into our range of services and to witness the positive impact it has on the lives of individuals in our care."

NTX prides itself on its team of dedicated professionals who provide a wide range of therapies and treatments for various mental health conditions. Their services include individual therapy, group therapy, ADHD testing, genetic testing, neuropsychological testing, and medication management. NTX specializes in treating depression, anxiety disorders, bipolar disorder, PTSD, OCD, eating disorders, and more.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform.™

The reference URL for this press release is located here NTX Introduces Groundbreaking Ketamine Treatment for Depression, Anxiety, PTSD, and OCD.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.